Walk before you run: Feasibility challenges and lessons learned from the PROCLAIM study, a multicenter randomized controlled trial of misoprostol for prevention of recurrent Clostridioides difficile during COVID-19.
Anaerobe
; 80: 102699, 2023 Apr.
Article
in En
| MEDLINE
| ID: mdl-36702174
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Clostridioides difficile
/
Misoprostol
/
Clostridium Infections
/
COVID-19
Type of study:
Clinical_trials
Limits:
Humans
Language:
En
Journal:
Anaerobe
Year:
2023
Document type:
Article
Affiliation country: